Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Catabasis, Duchenne UK announce partnership to evaluate edasalonexent in phase 2 non-ambulatory DMD trial
Catabasis, Duchenne UK announce partnership to evaluate edasalonexent in phase 2 non-ambulatory duchenne muscular dystrophy trial. (Credit: Belova59 from Pixabay)